RASSF1A promoter methylation correlates development, progression, and poor cancer-specific survival of renal cell carcinoma: trial sequential analysis

BACKGROUND: This meta-analysis evaluated the clinicopathologic and prognostic significance of RASSF1A promoter methylation in renal cell carcinoma (RCC). MATERIALS AND METHODS: The ORs or HRs and their 95% CIs were calculated. Trial sequential analysis was conducted. RESULTS: Twenty-two articles tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Qianfeng, Chen, Zhen, Shen, Jie, Fan, Min, Xue, Dong, Lu, Hao, Xu, Renfang, He, Xiaozhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304251/
https://www.ncbi.nlm.nih.gov/pubmed/30588036
http://dx.doi.org/10.2147/OTT.S183142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304251/
https://www.ncbi.nlm.nih.gov/pubmed/30588036
http://dx.doi.org/10.2147/OTT.S183142

Ejemplares similares